Relmada Therapeutics (RLMD)
(Delayed Data from NSDQ)
$2.77 USD
-0.03 (-1.07%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $2.74 -0.03 (-1.08%) 7:58 PM ET
2-Buy of 5 2
F Value B Growth C Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.56 | 0.00% |
Earnings Summary
For their last quarter, Relmada Therapeutics (RLMD) reported earnings of -$0.59 per share, beating the Zacks Consensus Estimate of $-0.83 per share. This reflects a positive earnings surprise of 28.92%. Look out for RLMD's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.56 per share, reflecting a year-over-year increase of 23.29%.
Earnings History
Price & Consensus
Zacks News for RLMD
Relmada (RLMD) Up on Positive Data for Anti-Depressant Candidate
RLMD: What are Zacks experts saying now?
Zacks Private Portfolio Services